Ir o contido principal

LIFE GENESYS

Resumo do proxecto

The main objective of the LIFE GENESYS project is to demonstrate an innovative and cost-efficient treatment for eliminating pharmaceuticals, antibiotic resistant genes and bacteria from hospital discharge, helping these institutions to produce toxic-free water effluents. The GENESYS solution is based on a treatment train consisting of a membrane bioreactor coupled to UV-LED reactor with H2O2 dosage. It allows an efficient and low-energy oxidation process. It also uses a digital tool to estimate antibiotic loads in hospital effluent, allowing hospitals to make informed decisions on antibiotics prescriptions. 

 

The specific objectives of the project are listed below. 

  • To develop and demonstrate the GENESYS solution at the Tauli Hospital wastewater collector in Sabadell, Spain, in a full-scale deployment capable of handling 240 m3/day of wastewater. There is currently no decentralised wastewater system in the Taulí Hospital collector, which is the main contributor of health-relevant ARG, ARB and recalcitrant pharmaceuticals to the sewer network.
  • To reduce the amount of CEC (pharmaceuticals, antibiotics, ARG and ARB) released in Tauli Hospital effluent and avoid its arrival into the Tiu Ripoll Wastewater Treatment Plant (WWTP), which was not designed to eliminate pharmaceutical compounds.
  • To prevent the release of recalcitrant human health relevant pharmaceuticals, ARG and ARB into the sewer system and consequently into the environment.
  • To demonstrate the technical performance and energy efficiency of UV-LED lamps compared to conventional mercury-based lamps.
  • To support hospitals and healthcare centres to make informed decisions on pharmaceuticals administration by considering the environmental and health risks of antimicrobial resistance dissemination.
  • To develop a sustainable business model for the commercialisation of the GENESYS solution and its main components.

 

Datos do proxecto

Título (idioma orixinal)
Eliminación de resistencias a antibióticos en efluentes hospitalarios
Ano de inicio
Ano de fin
Programa de financiación
LIFE
Ámbito do programa
Institución coordinadora
CETAQUA
Socios/Entidades colaboradoras

LABAQUA

APRIA SYSTEM

HOSPITAL UNIVERSITARI PARC TAULI

COMPANYIA D'AIGUES DE SABADELL SA

FUNDACIO INSTITUT D'INVESTIGACIÓ I INNOVACIÓ PARC TAULI

 CORPORACIO SANITARIA PARC TAULI DE SABADELL

Orzamento
2174721.50 €
Socios/Entidades colaboradoras

LABAQUA

APRIA SYSTEM

HOSPITAL UNIVERSITARI PARC TAULI

COMPANYIA D'AIGUES DE SABADELL SA

FUNDACIO INSTITUT D'INVESTIGACIÓ I INNOVACIÓ PARC TAULI

 CORPORACIO SANITARIA PARC TAULI DE SABADELL